Despite the clear association of TNF with alcoholic liver disease, treatment with the anti-TNF antibody infliximab has been proven detrimental in patients with alcoholic steatohepatitis due to increased rates of infection and mortality [71]. Here, TNF is linked to alcoholic liver diseases.